Cho Jang-Hyeon, Mao Chai-An, Klein William H
Department of Biochemistry and Molecular Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Mol Vis. 2012;18:2658-72. Epub 2012 Nov 12.
Retinal ganglion cell (RGC) death and optic nerve degeneration are complex processes whose underlying molecular mechanisms are only vaguely understood. Treatments commonly used for optic nerve degeneration have little long-term value and only prolong degeneration. Recent advances in stem cell replacement therapy offer new ways to overcome RGC loss by transferring healthy cells into eyes of afflicted individuals. However, studies on stem cell replacement for optic nerve degeneration are hampered by limitations of the available animal models, especially genetic models. We have developed a mouse model in which RGCs are genetically ablated in adult mice with subsequent degeneration of the optic nerve. In the study reported here, we used this model to determine whether embryonic retinal progenitor cells (RPCs) removed from donor retinas when RPCs are committing to an RGC fate could restore lost RGCs.
We used the RGC-depleted model as a host for transplanting donor green fluorescent protein (GFP)-labeled RPCs from embryonic retinas that are maximally expressing Atoh7, a basic helix-loop-helix gene essential for RGC specification. Dissociated GFP-labeled RPCs were characterized in situ by immunolabeling with antibodies against proteins known to be expressed in RPCs at embryonic day (E)14.5. Dissociated retinal cells were injected into the vitreous of one eye of RGC-depleted mice at two to six months of age. The injected and non-injected retinas were analyzed for gene expression using immunolabeling, and the morphology of optic nerves was assessed visually and with histological staining at different times up to four months after injection.
We demonstrate the successful transfer of embryonic GFP-labeled RPCs into the eyes of RGC-depleted mice. Many transplanted RPCs invaded the ganglion cell layer, but the efficiency of the invasion was low. GFP-labeled cells within the ganglion cell layer expressed genes associated with early and late stages of RGC differentiation, including Pou4f1, Pou4f2, NFL, Map2, and syntaxin. Several GFP-labeled cells were detected within the injected optic nerves of RGC-depleted mice, and in most cases, we observed a significant increase in the thickness of the RPC-injected optic nerves compared with non-injected controls. We also observed more bundled axons emanating from RPC-injected retinas compared with RGC-depleted controls.
The results offer a new approach for regenerating damaged optic nerves and indicate that a significant number of E14.5 RPCs are able to differentiate into RGCs in the foreign environment of the adult retina. However, the proportion of RPCs that populated the ganglion cell layer and contributed to the optic nerve was not sufficient to account for the increased thickness and higher number of axons. The results support the hypothesis that the injected E14.5 RPCs are contributing autonomously and non-autonomously to restoring damaged optic nerves.
视网膜神经节细胞(RGC)死亡和视神经变性是复杂的过程,其潜在的分子机制尚不清楚。常用于视神经变性的治疗方法长期价值不大,只是延缓了变性过程。干细胞替代疗法的最新进展为通过将健康细胞移植到患病个体的眼睛中来克服RGC损失提供了新方法。然而,视神经变性的干细胞替代研究受到现有动物模型(尤其是基因模型)局限性的阻碍。我们开发了一种小鼠模型,在成年小鼠中通过基因消融RGC,随后导致视神经变性。在本报告的研究中,我们使用该模型来确定当视网膜祖细胞(RPC)向RGC命运分化时从供体视网膜中取出的胚胎视网膜祖细胞是否可以恢复丢失的RGC。
我们使用RGC缺失模型作为宿主,移植来自胚胎视网膜的供体绿色荧光蛋白(GFP)标记的RPC。这些胚胎视网膜最大程度地表达Atoh7,这是一种对RGC特化至关重要的基本螺旋-环-螺旋基因。通过用针对已知在胚胎第14.5天(E)在RPC中表达的蛋白质的抗体进行免疫标记,对解离的GFP标记的RPC进行原位表征。将解离的视网膜细胞注射到2至6个月大的RGC缺失小鼠的一只眼睛的玻璃体中。使用免疫标记分析注射和未注射的视网膜的基因表达,并在注射后长达四个月的不同时间通过肉眼和组织学染色评估视神经的形态。
我们证明了胚胎GFP标记的RPC成功转移到RGC缺失小鼠的眼睛中。许多移植的RPC侵入了神经节细胞层,但侵入效率较低。神经节细胞层内的GFP标记细胞表达了与RGC分化早期和晚期相关的基因,包括Pou4f1、Pou4f2、NFL、Map2和 syntaxin。在RGC缺失小鼠的注射视神经内检测到几个GFP标记的细胞,在大多数情况下,我们观察到与未注射对照相比,注射RPC的视神经厚度显著增加。与RGC缺失对照相比,我们还观察到从注射RPC的视网膜发出的轴突束更多。
这些结果为受损视神经的再生提供了一种新方法,并表明大量E14.5 RPC能够在成年视网膜的外来环境中分化为RGC。然而,填充神经节细胞层并对视神经有贡献的RPC比例不足以解释厚度增加和轴突数量增加的原因。这些结果支持以下假设:注射的E14.5 RPC自主和非自主地有助于恢复受损的视神经。